Soin Therapeutics is a pharmaceutical company that is developing new medications to treat rare, orphan diseases. Our lead product is a novel formulation of naltrexone for patients who suffer from complex regional pain syndrome (CRPS). It has received orphan drug status from the FDA. CRPS is a painful, debilitating disease and we believe we found a solution that can be helpful to many people who are suffering.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.